Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$40.14

-0.51 (-1.25%)

, FOX

21st Century Fox

$26.61

-0.05 (-0.19%)

11:48
08/25/17
08/25
11:48
08/25/17
11:48

Box Office Battle: Cinemas looking at worst August weekend in almost 25 years

This weekend could be the worst August weekend the U.S. box office has seen in almost twenty-five years, with a top twelve that may not reach $50M combined, according to Box Office Mojo, which noted that this hasn't happened since August of 1993. One of the biggest factors expected to impact the weekend is Saturday night's Mayweather-McGregor boxing match. Lionsgate's (LGF.A, LGF.B) "The Hitman's Bodyguard," an action comedy starring Ryan Reynolds and Samuel L. Jackson that opened last weekend and finished atop the box office, is expected to remain on top this weekend with a domestic gross of about $10M. Time Warner's (TWX) Warner Bros/New Line's horror prequel "Annabelle: Creation" is expected to finish in second place with a gross of about $7.5M. The Weinstein Co.'s animated feature "Leap!," which is opening this weekend, is expected to gross $4M-$5M. Warner Bros.' war epic "Dunkirk," which is in its sixth weekend at theaters, is expected to gross an additional $4M-$5M. Other publicly traded companies in filmmaking include 21st Century Fox (FOX, FOXA), Comcast (CMCSA, CMCSK), Disney (DIS), Sony (SNE), and Viacom (VIA, VIAB).

CMCSA

Comcast

$40.14

-0.51 (-1.25%)

FOX

21st Century Fox

$26.61

-0.05 (-0.19%)

VIAB

Viacom

$28.65

0.04 (0.14%)

SNE

Sony

$38.55

0.36 (0.94%)

DIS

Disney

$101.69

0.17 (0.17%)

CMCSK

Comcast

FOXA

21st Century Fox

$27.10

-0.05 (-0.18%)

VIA

Viacom

$37.75

-0.15 (-0.40%)

LGF.B

Lionsgate

$27.99

0.35 (1.27%)

TWX

Time Warner

$101.40

0.08 (0.08%)

LGF.A

Lionsgate

$29.55

0.53 (1.83%)

  • 05

    Sep

  • 11

    Sep

  • 27

    Sep

CMCSA Comcast
$40.14

-0.51 (-1.25%)

08/03/17
08/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris citing an attractive valuation, a combination of solid trends at Cable Communications and NBCU content momentum, and strong balance sheet. 2. Caterpillar (CAT) upgraded to Neutral from Underweight at Atlantic Equities. 3. SodaStream (SODA) upgraded to Positive from Neutral at Susquehanna. 4. Walker & Dunlop (WD) upgraded to Outperform from Market Perform at JMP Securities with analyst Steven DeLaney saying investors may be overly focusing on quarterly results and the reduction in the company's gain on sale margin guidance for the second half of the year. 5. Oshkosh (OSK) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ross Gilardi citing better than expected third quarter results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/17
GUGG
08/03/17
UPGRADE
GUGG
Buy
Comcast upgraded to Buy from Neutral at Guggenheim
Guggenheim analyst Michael Morris upgraded Comcast to Buy and raised its price target to $46 to reflect an attractive valuation, a combination of solid trends at Cable Communications and NBCU content momentum, and strong balance sheet. Morris expects reduced 2018 Cable programming cost growth, advertising momentum, and a strong film slate driving investor interest.
08/14/17
SBSH
08/14/17
NO CHANGE
SBSH
Comcast, Altice USA could jointly bid for Charter, says Citi
Citi analyst Jason Bazinet presented a scenario to investors this morning where Comcast (CMCSA) and Altice USA (ATUS) put in a joint bid for Charter Communications (CHTR). He assumes Charter receives a $450 per share bid. The stock on Friday closed down $4.19 to $394.49. In this scenario, the analyst sees Altice's equity rising 10% and Comcast trading flat. Bazinet has Buy ratings on all three names.
08/14/17
OPCO
08/14/17
NO CHANGE
Target $46
OPCO
Outperform
Comcast remains undervalued, says Oppenheimer
After meeting with management, Oppenheimer analyst Timothy Horan says Comcast remains "very optimistic" on its business model, as does he, and the company remains "undervalued versus its peers." The analyst also believes management is unlikely to make any major acquisitions given its strong position, regulatory uncertainty, and high relative valuations of targets. Horan reiterates an Outperform rating and $46 price target on the shares.
FOX 21st Century Fox
$26.61

-0.05 (-0.19%)

07/25/17
OTRG
07/25/17
DOWNGRADE
OTRG
Mixed
21st Century Fox downgraded to Mixed from Positive at OTR Global
OTR Global downgraded 21st Century Fox to Mixed from Positive
08/01/17
FBCO
08/01/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox, Sky deal to take longer to clear, says Credit Suisse
Credit Suisse analyst Omar Sheikh continues to believe the Sky (SKYAY) transaction will eventually receive full regulatory approval, but highlights there is an elevated risk to the deal if it is referred to the CMA, and at best an extended period before it gets cleared. Meanwhile, he believes the 2018 21st Century Fox (FOXA) organic equity story looks compelling, and reiterates an Outperform rating and $37 price target on the shares.
08/08/17
BNCH
08/08/17
NO CHANGE
BNCH
Buy
Fox-ION 'rumors' most likely a negotiating tactic, says Benchmark
Benchmark analyst Daniel Kurnos highlighted a "slew" of "inconsistencies" that make him skeptical of last week's "unsubstantiated rumor published by Bloomberg" regarding Fox (FOXA) potentially forming a JV with ION and pulling all of its affiliate agreements from Sinclair (SBGI), concluding in a note to investors that this was "just another negotiating tactic by the network." Fox's "cozy" agreements with Tribune (TRCO) may get disrupted by Sinclair's acquisition, added Kurnos, who has a Buy rating on Sinclair shares.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
VIAB Viacom
$28.65

0.04 (0.14%)

08/04/17
EVER
08/04/17
NO CHANGE
Target $48
EVER
Outperform
Evercore ISI would be a buyer of Viacom near-term weakness at Evercore ISI
Evercore ISI analyst Vijay Jayant would use weakness in Viacom share related to disappointing guidance as a buying opportunity. The analyst believes the company is heading int the right direction under new CEO Bob Bakish, and said there are some early signs that his restructuring plan is working. Jayant rates Viacom an Outperform with a $48 price target.
07/17/17
JPMS
07/17/17
NO CHANGE
JPMS
Overweight
Viacom shares offer 'great value' at current levels, says JPMorgan
JPMorgan analyst Alexia Quadrani says Viacom over the past few months experienced improving ratings across several of its key networks, which she believes supports a positive outlook for advertising improvement. Shares of Viacom present "great value at these levels," Quadrani tells investors in a research note. She reiterates an Overweight rating on the stock.
08/04/17
ATLE
08/04/17
DOWNGRADE
ATLE
Underweight
Viacom downgraded to Underweight from Neutral at Atlantic Equities
07/26/17
WELS
07/26/17
NO CHANGE
WELS
Scripps Networks could be acquired for $91-$95 per share, says Wells Fargo
After the Wall Street Journal reported that Discovery (DISCA) and Viacom (VIAB) are interested in buying Scripps' (SNI) assets, Wells Fargo estimates that Scripps could be acquired for $91-$95 per share. The firm believes that the acquirer or acquirers could realize a total of about $175M of non-programming expense synergies. It keeps a Market Perform rating on Scripps.
SNE Sony
$38.55

0.36 (0.94%)

04/25/17
04/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sony (SNE) initiated with an Outperform at Bernstein. 2. Rockwell Collins (COL) reinstated with a Sell at Goldman Sachs. 3. Idera Pharmaceuticals (IDRA) initiated with an Outperform at Baird. 4. GasLog (GLOG) initiated with an Outperform at Credit Suisse. 5. Fitbit (FIT) initiated with a Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/17
BERN
06/08/17
NO CHANGE
BERN
Sony price target raised to $47 from $41 at Bernstein
Bernstein analyst David Dai raised his price target on Sony as he thinks that the company's growth will be boosted by strong sales of its game and image sensors. He keeps an Outperform rating on the stock.
04/25/17
BERN
04/25/17
INITIATION
BERN
Outperform
Sony initiated with an Outperform at Bernstein
Bernstein analyst David Dai started coverage of Sony with an Outperform rating. The analyst says that Sony's image sensor business should be boosted by advances in computers' communications capabilities and by the proliferation of VR/AR. The analyst adds that the company's PlayStation console "will maintain the leading position in tethered VR for the next three years at least," and he says that this status "should strengthen the PlayStation ecosystem." ,
04/21/17
JPMS
04/21/17
UPGRADE
JPMS
Overweight
Sony upgraded to Overweight from Neutral at JPMorgan
DIS Disney
$101.69

0.17 (0.17%)

08/14/17
PIPR
08/14/17
NO CHANGE
Target $215
PIPR
Overweight
Piper survey shows Disney loss having minimal impact on Netflix
Piper Jaffray analyst Michael Olson says that while Disney (DIS) ending its agreement for distribution of certain content is a negative headline, it will have minimal impact on the Netflix (NFLX). His firm surveyed over 500 U.S. Netflix subscribers and asked what percent of their Netflix time is spent on Disney. Piper found that "only" around 20% of subscribers spend greater than 10% of their Netflix time viewing Disney content. The analyst expects "almost none" of the remaining 80% of subscribers will cancel due to the loss of Disney. Further, the 20% of heavier Disney viewers are unlikely to cancel unless Disney accounts for a large portion, like greater than 40%, of their Netflix viewing time, Olson tells investors in a research note. He points out that Netflix shares are down 4% since Disney's announcement on August 8. The analyst keeps an Overweight rating on Netflix shares with a $215 price target. The streaming service closed Friday up $2.26 to $171.40.
08/15/17
PIPR
08/15/17
NO CHANGE
Target $130
PIPR
Overweight
Piper survey shows 'sizable' interest in Disney streaming service
Piper Jaffray analyst Stan Meyers says his firm's survey of over 1,000 consumers found a "sizable," 23% interest in subscribing to a Disney/Pixar streaming service. Of those interested, 37% would pay more than $5 per month, Meyers tells investors in a research note. The analyst estimates 4M subscribers will be Disney's (DIS) equilibrium point between launching its own service and licensing to Netflix (NFLX), which will end in 2019. Disney's entry into direct-to-consumer streaming should "unlock some of its library value, enhance leverage with distributors, and open the door to potentially cross sell its consumer products," Meyers argues. He keeps an Overweight rating on Disney shares with a $130 price target. The stock closed yesterday down 59c to $101.40.
08/18/17
GSCO
08/18/17
NO CHANGE
GSCO
Disney Internet TV service is right strategy, says Goldman Sachs
Goldman Sachs analyst Drew Borst says that Disney's upcoming video streaming service could be dilutive to its profits in the first year before reaching break even in years two and three. However, the analyst says that the move will beat fruit over the long-term because it will allow the company "to develop a more direct relationship with consumers." and monetize "broadband-only U.S. households." The analyst cut his price target on the shares to $119 from $133 but keeps a Buy rating on the stock and keeps the stock on the firm's Conviction Buy List.
08/22/17
PIPR
08/22/17
NO CHANGE
PIPR
Piper finds nearly 20% of surveyed consumers would pay to stream ESPN
In part two of a survey of over 1,000 consumers regarding Disney's recent streaming plan announcements, Piper Jaffray analyst Stan Meyers says 19% of those surveyed expressed interest in subscribing to an ESPN streaming service. Of those interested, 41% would pay more than $5 per month, Meyers tells investors. The analyst estimates the service can reach 6M subscribers over the next few years once the complete ESPN streaming service is launched. Meyers, who sees ESPN streaming helping Disney with its leverage with multichannel video programming distributors, keeps an Overweight rating and $130 price target on Disney shares.
CMCSK Comcast

04/24/17
OPCO
04/24/17
NO CHANGE
OPCO
Sprint, DISH the only assets for sale, says Oppenheimer
Oppenheimer analyst Timothy Horan noted that wireless companies will be allowed to discuss M&A, and says he sees Sprint (S) and possibly DISH (DISH) as the only assets for sale. The analyst believes the most likely outcome is for consolidation around the four major wireless providers, something along the lines of Charter (CHTR)/Sprint, T-Mobile (TMUS)/Comcast (CMCSA; CMCSK), Verizon (VZ)/DISH, with AT&T's (T) position "fairly solidified" with DirectTV/Time Warner (TWX). Further, Horan suspects Sprint will be sold first, most likely to Charter, although T-Mobile is a possibility and could be the controlling company/management and likely paying a premium for Sprint.
04/20/17
BTIG
04/20/17
NO CHANGE
BTIG
Comcast should try 'hail mary' Charter acquisition, says BTIG
BTIG analyst Rich Greenfield makes the case that Comcast's (CMCSA) "window for M&A is simply to enticing too ignore" and lays out six potential targets that would "truly be transformative," with his top pick among the group being Charter (CHTR). A combination of Charter with Comcast would have "all of the benefits of the legacy Time Warner Cable deal with even more scale" and even though odds of approval are no better than 50/50, it is worth throwing that "hail-mary," Greenfield tells investors. The other five possible deals that Greenfield makes the case for are Disney (DIS), Verizon (VZ), Netflix (NFLX), T-Mobile (TMUS) and Snap Inc.'s (SNAP) Snapchat.
02/03/17
OPCO
02/03/17
NO CHANGE
OPCO
Content/application acquisitions more likely for Verizon, says Oppenheimer
Oppenheimer analyst Timothy Horan says that while he does see a merger with Charter (CHTR) and especially with Comcast (CMCSA) working financially, he believes Verizon (VZ) has its sights set on becoming a platform for digital content/apps monetized with programmatic advertising. This, combined with using wireless technologies to replace wireline broadband, could be "very disruptive to the cable industry," he adds. The analyst sees further acquisitions of content/application companies as more likely for Verizon.
FOXA 21st Century Fox
$27.10

-0.05 (-0.18%)

08/11/17
PIPR
08/11/17
INITIATION
Target $35
PIPR
Overweight
21st Century Fox initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Stan Meyers started 21st Century Fox with an Overweight rating and $35 price target. Fox has some of the best mix of content and remains undervalued relative to peers, the analyst contends.
VIA Viacom
$37.75

-0.15 (-0.40%)

06/22/17
LOOP
06/22/17
NO CHANGE
Target $37
LOOP
Hold
Viacom unlikely to see boost from 'Transformers' sequel, says Loop Capital
Loop Capital analyst David Miller believes Viacom's "Transformers" franchise is "somewhat long in the tooth" and he sees both the opening weekend and overall domestic grosses for the fifth installment, "The Last Knight" to be muted. He does note, though, that he expects international results to be "quite strong" for the film. Miller keeps a Hold rating on Viacom and lowered his price target to $37 from $39.
06/15/17
BERN
06/15/17
NO CHANGE
BERN
Viacom shares could tumble to $2.50, says Bernstein
Bernstein analyst Todd Juenger says that Viacom could drop to $2.50 per share if its current $3B EBITDA drops to $2B, and its EBITDA multiple drops to six times. The analyst says that this scenario is "not crazy," since the company's EBITDA fell 33% from fiscal 2014 to fiscal 2016 "during a rip-roaring advertising market and the early days of cord-cutting." He keeps a $29 price target and Underperform rating on the shares.
06/12/17
JPMS
06/12/17
NO CHANGE
Target $48
JPMS
Overweight
JPMorgan calls Paramount 'hidden jewel' of Viacom
JPMorgan analyst Alexia Quadrani believes investors have "largely overlooked" Viacom's Paramount asset following the unit's $445M loss last year. The analyst sees a "path toward profitability in the coming years" for Paramount following "wide-ranging management and strategy changes." She calls the studio Viacom's "hidden jewel" and keeps an Overweight rating on the shares with a $48 price target.
LGF.B Lionsgate
$27.99

0.35 (1.27%)

05/19/17
RBCM
05/19/17
NO CHANGE
RBCM
CBS is predator and prey,' says RBC Capital
As the situation deteriorates for media companies due to accelerating cord cutting and weak ad trends, RBC Capital analyst Steven Cahall thinks that companies in the sector will look to consolidate.He believes that CBS (CBS) could buy Lionsgate (LGF.A,LGF.B) in a deal that would be 5% accretive and be viewed favorably by the market or the TV network could be acquired by Verizon (VZ). However, the analyst thinks the most likely scenario is an acquisition of Viacom (VIAB) by CBS.
07/21/17
07/21/17
NO CHANGE

Lionsgate price target raised to $36 from $29 at Loop Capital
Loop Capital analyst David Miller said that while Lionsgate shares have grinded higher as the company "continues to do what it has always done very well," he also has confidence that it is well ahead of plan on Starz synergies and that it has potential from "second-window" sales of streaming rights and orders from OTT platforms. Miller raised his price target on Lionsgate B shares to $36 from $29 and keeps a Buy rating on the name.
06/02/17
06/02/17
UPGRADE
Target $31

Buy
Lionsgate upgraded to Buy at SunTrust
As previously reported, SunTrust upgraded Lionsgate (LGF.B) to Buy from Hold and raised its price target to $31 from $28. Analyst Matthew Thornton said expectations into the Q4 report were cautious as evidenced by the stock reaction to earnings, despite FY18 OIBDA guidance that was 3% below consensus. Now that FY18 OIBDA, Motion Pictures, and TV Production expectations have been re-based, Thornton believes estimates are now achievable, and said Starz's upcoming original releases should help sub growth near-term. The analyst said deleveraging is ahead of plan and could result in buybacks in FY19, and continues to expect ongoing consolidation of content and distribution, making Lionsgate a target given its assets and size.
05/30/17
05/30/17
NO CHANGE

Lionsgate shares likely to rerate after earnings, says RBC Capital
RBC Capital analyst Steven Cahall says that Lionsgate's better than expected Q4 results and guidance for adjusted OIBDA growth in the teen percentage levels has made investors more aware of and confident in the stock. He expects the shares to rerate and keeps a $32 price target and Outperform rating on the shares.
TWX Time Warner
$101.40

0.08 (0.08%)

08/07/17
EVER
08/07/17
DOWNGRADE
EVER
In Line
Time Warner downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Vijay Jayant dowgnraded Time Warner (TWX) to In Line saying shares are trading 5% below the $108 merger price with AT&T (T).
08/03/17
JEFF
08/03/17
DOWNGRADE
Target $105
JEFF
Hold
Time Warner downgraded to Hold from Buy at Jefferies
Jefferies analyst John Janedis downgraded Time Warner (TWX) to Hold saying the AT&T (T) takeover appears on track to close in Q4. The analyst keeps a $105 price target for the shares.
08/04/17
LEHM
08/04/17
DOWNGRADE
LEHM
Equal Weight
Time Warner downgraded to Equal Weight from Overweight at Barclays
07/13/17
BOFA
07/13/17
DOWNGRADE
Target $39
BOFA
Neutral
AT&T downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst David Barden downgraded AT&T (T) to Neutral from Buy and cut its price target to $39 from $46 on reduced visibility into catalysts such as corporate tax reform and potential headwinds from the Time Warner (TWX) merger. Barden expects the associated overhang of $40B in new equity issuance and the tightening of the deal spread will increasingly pressure AT&T's stock. Additionally, the analyst trimmed Q2 estimates due to a seasonally difficult quarter saying video, voice, and broadband metrics are expected to be challenging and AT&T is losing share in each category.
LGF.A Lionsgate
$29.55

0.53 (1.83%)

06/27/17
06/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Alex Yao resumed coverage of Alibaba (BABA) Group with an Overweight rating and $190 price target following a period of restriction. The rating is unchanged and the price target is raised from $140. 2. SunTrust analyst Terry Tillman initiated Salesforce (CRM) with a Buy and a $110 price target and views its as a core holding for large-cap investors. 3. Citi analyst Joel Beatty started Arena Pharmaceuticals (ARNA) with a Buy rating and $23 price target. 4. Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. 5. Cantor Fitzgerald analyst Louise Chen assumed coverage of Amarin (AMRN) with an Overweight rating and $10 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/17
DBAB
06/27/17
INITIATION
Target $29
DBAB
Hold
Lionsgate initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. The analyst views consensus estimates as too high but sees potential upside through consolidation.

TODAY'S FREE FLY STORIES

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

, ABBV

AbbVie

$118.60

3.7 (3.22%)

04:55
02/18/18
02/18
04:55
02/18/18
04:55
Conference/Events
American Academy of Dermatology holds annual meeting »

2018 AAD Annual Meeting…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

AGN

Allergan

$164.04

-0.43 (-0.26%)

ALIOF

Actelion

ARDX

Ardelyx

$5.80

-0.2 (-3.33%)

BVX

Bovie Medical

$2.50

0.1 (4.17%)

CELG

Celgene

$95.26

-0.88 (-0.92%)

CUTR

Cutera

$48.40

-2.1 (-4.16%)

HSIC

Henry Schein

$69.52

1.14 (1.67%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

LLY

Eli Lilly

$78.97

0.95 (1.22%)

LMNS

Lumenis

MYGN

Myriad Genetics

$32.81

-0.57 (-1.71%)

MYL

Mylan

$42.14

0.49 (1.18%)

NVS

Novartis

$86.91

0.23 (0.27%)

PFE

Pfizer

$36.26

0.55 (1.54%)

PG

Procter & Gamble

$82.60

0.19 (0.23%)

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNY

Sanofi

$39.91

0.19 (0.48%)

UL

Unilever; also tag UN

$53.55

-0.22 (-0.41%)

UN

Unilever; also tag UL

$54.59

-0.15 (-0.27%)

WTKWY

Wolters Kluwer

$49.37

-0.27 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 12

    Mar

  • 12

    Mar

  • 25

    Mar

  • 29

    Mar

  • 04

    Apr

  • 23

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 17

    May

  • 30

    May

  • 13

    Nov

MRVL

Marvell

$22.68

-0.06 (-0.26%)

, CAVM

Cavium

$87.16

-0.09 (-0.10%)

14:55
02/17/18
02/17
14:55
02/17/18
14:55
Conference/Events
Cavium to host special shareholder meeting »

Special Shareholder…

MRVL

Marvell

$22.68

-0.06 (-0.26%)

CAVM

Cavium

$87.16

-0.09 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 08

    Mar

CAVM

Cavium

$87.16

-0.09 (-0.10%)

, MRVL

Marvell

$22.68

-0.06 (-0.26%)

14:51
02/17/18
02/17
14:51
02/17/18
14:51
Conference/Events
Marvell to host special shareholder meeting »

Special Shareholder…

CAVM

Cavium

$87.16

-0.09 (-0.10%)

MRVL

Marvell

$22.68

-0.06 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

DEL

Deltic Timber

$98.45

1.77 (1.83%)

, PCH

Potlatch

$54.75

0.75 (1.39%)

14:45
02/17/18
02/17
14:45
02/17/18
14:45
Conference/Events
Potlatch to host special shareholder meeting »

Special Shareholder…

DEL

Deltic Timber

$98.45

1.77 (1.83%)

PCH

Potlatch

$54.75

0.75 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PCH

Potlatch

$54.75

0.75 (1.39%)

, DEL

Deltic Timber

$98.45

1.77 (1.83%)

14:42
02/17/18
02/17
14:42
02/17/18
14:42
Conference/Events
Deltic Timber to host special shareholder meeting »

Special shareholder…

PCH

Potlatch

$54.75

0.75 (1.39%)

DEL

Deltic Timber

$98.45

1.77 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$20.42

0.67 (3.39%)

09:31
02/17/18
02/17
09:31
02/17/18
09:31
Periodicals
Snap CEO sold $50M in stock this week, Recode reports »

Snap CEO Evan Spiegel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

, MPSYY

MorphoSys

$46.29

1.29 (2.87%)

09:27
02/17/18
02/17
09:27
02/17/18
09:27
Hot Stocks
Galapagos NV, MorphoSys present results from Phase 1 study with MOR106 in AD »

Galapagos NV (GLPG) and…

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

MPSYY

MorphoSys

$46.29

1.29 (2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$360.53

-0.47 (-0.13%)

09:22
02/17/18
02/17
09:22
02/17/18
09:22
Hot Stocks
Lockheed Martin receives Freedom-variant FFG conceptual design contract »

The U.S. Navy awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

  • 30

    May

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

, UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

09:11
02/17/18
02/17
09:11
02/17/18
09:11
Periodicals
Bears, bulls battle over Under Armour, Barron's says »

In a follow-up story,…

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOV

Hovnanian

$2.24

0.12 (5.66%)

09:04
02/17/18
02/17
09:04
02/17/18
09:04
Periodicals
Hovnanian stock too cheap to ignore, Barron's says »

Hovnanian Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

, JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

09:00
02/17/18
02/17
09:00
02/17/18
09:00
Periodicals
JPMorgan, Walmart cash flow yields exceed dividend yields, Barron's says »

The cash flow yields of…

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

WMT

Walmart

$104.78

1.55 (1.50%)

PFE

Pfizer

$36.26

0.55 (1.54%)

CSCO

Cisco

$44.33

0.25 (0.57%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

PEP

PepsiCo

$111.06

0.09 (0.08%)

MMM

3M

$236.67

1.8 (0.77%)

BMY

Bristol-Myers

$68.96

-0.02 (-0.03%)

UTX

United Technologies

$129.26

-0.74 (-0.57%)

TXN

Texas Instruments

$104.47

-0.1 (-0.10%)

ABT

Abbott

$60.17

0.67 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 13

    Mar

  • 29

    Mar

  • 04

    Apr

  • 13

    Apr

  • 30

    May

  • 14

    Jul

  • 12

    Oct

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

, GOOG

Alphabet

$1,094.80

5.28 (0.48%)

08:56
02/17/18
02/17
08:56
02/17/18
08:56
Periodicals
Alphabet, Citi well positioned for later stages of market rally, Barron's says »

It is time for investors…

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

GOOG

Alphabet

$1,094.80

5.28 (0.48%)

C

Citi

$76.82

-0.26 (-0.34%)

CMI

Cummins

$165.60

0.58 (0.35%)

LRCX

Lam Research

$187.91

2.2 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 18

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    May

GE

General Electric

$15.05

0.2 (1.35%)

08:48
02/17/18
02/17
08:48
02/17/18
08:48
Periodicals
General Electric stock could drop another 10%, Barron's says »

General Electric lost $6B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

, VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

08:32
02/17/18
02/17
08:32
02/17/18
08:32
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

PWR

Quanta Services

$35.07

0.24 (0.69%)

EXP

Eagle Materials

$102.75

-3.83 (-3.59%)

FLR

Fluor

$57.63

-0.22 (-0.38%)

USCR

U.S. Concrete

$78.00

-1.4 (-1.76%)

ACM

Aecom

$35.36

0.08 (0.23%)

CBI

CB&I

$18.71

0.04 (0.21%)

GVA

Granite Construction

$60.36

2.69 (4.66%)

CAT

Caterpillar

$156.29

-3.69 (-2.31%)

MLM

Martin Marietta

$216.25

-6.34 (-2.85%)

V

Visa

$121.85

-0.43 (-0.35%)

AA

Alcoa

$47.36

-0.21 (-0.44%)

ARNC

Arconic

$25.36

0.14 (0.56%)

CENX

Century Aluminum

$24.12

1.85 (8.31%)

X

U.S. Steel

$44.75

5.76 (14.77%)

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

AKS

AK Steel

$5.96

0.72 (13.74%)

CLF

Cleveland-Cliffs

$7.92

0.55 (7.46%)

NUE

Nucor

$68.54

2.96 (4.51%)

MT

ArcelorMittal

$36.48

1.19 (3.37%)

TKR

Timken

$45.00

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 01

    Mar

  • 14

    Mar

  • 23

    May

  • 30

    May

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
Cambridge Healthtech Institute to hold a conference »

Molecular Med Tri-Con…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

, ABBV

AbbVie

$118.60

3.7 (3.22%)

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
American Academy of Dermatology holds annual meeting »

2018 AAD Annual Meeting…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

AGN

Allergan

$164.04

-0.43 (-0.26%)

ALIOF

Actelion

ARDX

Ardelyx

$5.80

-0.2 (-3.33%)

BVX

Bovie Medical

$2.50

0.1 (4.17%)

CELG

Celgene

$95.26

-0.88 (-0.92%)

CUTR

Cutera

$48.40

-2.1 (-4.16%)

HSIC

Henry Schein

$69.52

1.14 (1.67%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

LLY

Eli Lilly

$78.97

0.95 (1.22%)

LMNS

Lumenis

MYGN

Myriad Genetics

$32.81

-0.57 (-1.71%)

MYL

Mylan

$42.14

0.49 (1.18%)

NVS

Novartis

$86.91

0.23 (0.27%)

PFE

Pfizer

$36.26

0.55 (1.54%)

PG

Procter & Gamble

$82.60

0.19 (0.23%)

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNY

Sanofi

$39.91

0.19 (0.48%)

UL

Unilever; also tag UN

$53.55

-0.22 (-0.41%)

UN

Unilever; also tag UL

$54.59

-0.15 (-0.27%)

WTKWY

Wolters Kluwer

$49.37

-0.27 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 12

    Mar

  • 12

    Mar

  • 25

    Mar

  • 29

    Mar

  • 04

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 17

    May

  • 30

    May

  • 13

    Nov

MIDD

Middleby

$135.00

1.94 (1.46%)

18:01
02/16/18
02/16
18:01
02/16/18
18:01
Hot Stocks
Middleby acquires Hinds-Bock Corporation, terms not disclosed »

Middleby announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.14

0.14 (0.38%)

, TWX

Time Warner

$95.37

0.38 (0.40%)

17:37
02/16/18
02/16
17:37
02/16/18
17:37
Periodicals
Breaking Periodicals news story on AT&T, Time Warner »

Judge says to rule on …

T

AT&T

$37.14

0.14 (0.38%)

TWX

Time Warner

$95.37

0.38 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

CARS

Cars.com

$29.27

0.33 (1.14%)

17:31
02/16/18
02/16
17:31
02/16/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Cars.com »

Starboard raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONTX

Onconova

$1.07

0.01 (0.94%)

17:29
02/16/18
02/16
17:29
02/16/18
17:29
Hot Stocks
683 Capital reports 21.8% stake in Onconova, says shares undervalued »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

17:26
02/16/18
02/16
17:26
02/16/18
17:26
Hot Stocks
General Dynamics awarded $148.9M government contract modification »

General Dynamics Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$2.39

0.04 (1.70%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Antares Pharma »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Huntington Ingalls awarded $1.43B government contract modification »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIT

AMCON Distributing

$87.50

0.13 (0.15%)

17:24
02/16/18
02/16
17:24
02/16/18
17:24
Hot Stocks
Breaking Hot Stocks news story on AMCON Distributing »

Hale Partnership reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$41.09

-0.76 (-1.82%)

, TSLA

Tesla

$335.49

1.425 (0.43%)

17:11
02/16/18
02/16
17:11
02/16/18
17:11
Periodicals
Chevy Bolt sales bolstered by Tesla delays, tax credit worries, Reuters says »

Certain potential buyers…

GM

General Motors

$41.09

-0.76 (-1.82%)

TSLA

Tesla

$335.49

1.425 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.